Latest From Biotech Now

Diabetes and Biotechnology: A Shared History…A Great Future

diabetes-thumb

By David Welch, President/Senior Producer at M2 MultiMedia One of my closest childhood friends suffered from Type I Diabetes. Like millions of other children and adults his daily life was frequently interrupted with finger pokes, sugar level tests, and insulin shots. Having grown up with a friend afflicted with Diabetes and knowing dozens of others, throughout my life, with the same disease, it was very rewarding to produce a film on the topic. Although Bobby and Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

For Preventing Hunger, Biotechnology is Key

Calestous Juma

The journal Nature recently published an article authored by Calestous Juma, director of the Agricultural Innovation in Africa Project at the Harvard Kennedy School. To survive the droughts, wars and other major causes of famine, Africa must embrace technologies that enable it to produce more, better food with less effort. Juma argues, “if African countries can’t plant genetically modified crops to produce more and healthier food, vulnerable populations will be at risk.” Indeed, without the Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Biotech Remains Strong in Florida

FLbiotech-thumb

Florida has always attracted visionaries – from Walt Disney to Kennedy Space Center. The ambition of great men helped transform inhospitable swamps into engines of the economy. However, with no income tax, and a large retiree population, Florida’s revenue long depended on booming tourism and the sales tax revenue it brought in. In the 1990’s, Florida’s leaders began to change that. Enterprise Florida was born. This public/private partnership was designed to identify and provide incentives Read More >

Public Policy  |  1 Comment  |  Email This Post
Tags: , , , ,

State Biotech Advocates Share Best Practices

CSBA

Last week the Council of State Bioscience Associations (CSBA) held its annual retreat in Austin, TX, where 42 different state-based bioscience advocacy organization gathered to discuss legislative and regulatory best practices that support bioscience industry development. More than 90 invited participants engaged in discussions covering the topics of economic development initiatives, upcoming federal and state legislative industry priorities, and advocacy campaigns in the digital era. BIO’s State Government Relations team would like to once again Read More >

Events  |  1 Comment  |  Email This Post
Tags: , , ,

NIH Licensing Efforts Target Start-Ups

NIH_Logo

The National Institutes of Health (NIH) has developed a new short-term licensing arrangement they hope will encourage licensing of NIH and FDA inventions to start-up companies.  The NIH Start-Up Exclusive License Agreements targets start-up companies less than 5 years old, with less than $5M in raised capital, and fewer thans than 50 employees.  By offering an exclusive license, they hope to accelerate the technology transfer process.  However, this temporary pilot program runs only until September 30, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,